Physician profile
Kevin Chen
NPI 1255727160
$20,268.79
in general payments reported to CMS, 2019-2025
14 companies · $4,382 in 2025
The $4,382 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $42.10 · 2021: $126 · 2022: $392 · 2023: $1,586 · 2024: $14K · 2025: $4,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $17K · Food and Beverage: $2,992 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $16,562.54 |
| Food and Beverage | $2,992.05 |
| Education | $154.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $13,916.08 | 2023-2025 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided, Igt Devices Undivided |
| Abbott Laboratories | $2,871.57 | 2022-2025 | Perclose Proglide, Esprit, Jeti Peripheral Catheter |
| Abiomed | $1,480.12 | 2023-2024 | Impella |
| Boston Scientific Corporation | $785.43 | 2025 | General - Vascular Access |
| Inari Medical, INC. | $314.10 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $258.92 | 2020-2025 | Lifevest |
| Zoll Circulation INC | $230.51 | 2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Depuy Synthes Sales INC. | $113.66 | 2022 | |
| Shockwave Medical, INC | $106.94 | 2022 | |
| Edwards Lifesciences Corporation | $90.17 | 2022 | |
| Lantheus Medical Imaging, INC. | $47.01 | 2020-2021 | |
| Medtronic, INC. | $20.53 | 2025 | Symplicity G3 |
| Cordis US Corp. | $18.99 | 2025 | Mynxgrip |
| Astrazeneca Pharmaceuticals LP | $14.76 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.